Temozolomide plus thalidomide in patients with brain metastases from melanoma: A phase II study

  • Hwu W
  • Lis E
  • Menell J
 et al. 
  • 10


    Mendeley users who have this article in their library.
  • 89


    Citations of this article.


Temozolomide plus thalidomide is a promising oral combination regimen for the treatment of metastatic melanoma. The current Phase II study examined the efficacy and safety of this combination in chemotherapy-naive patients with brain metastases.

Author-supplied keywords

  • Brain metastasis
  • Melanoma
  • Temozolomide
  • Thalidomide

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Wen Jen Hwu

  • Eric Lis

  • Jennifer H. Menell

  • Katherine S. Panageas

  • Lynne A. Lamb

  • Janene Merrell

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free